A few clinical studies showed that vascular endothelial growth factor VEGF, a major angiogenic protein, was elevated in circulation and tissues in HHT patients (Sadick et al., 2005a,b). Here, VEGFA is linked to hereditary hemorrhagic telangiectasia.